Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate von Sievers, E.L., Appelbaum, F.R., Spielberger, R.T., Forman, S.J., Flowers, D., Smith, F.O., Shannon-Dorcy, K., Berger, M.S., Bernstein, I.D.

Volltext

Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via multiparameter flow cytometry in adult acute myeloid leukemia von Zhou, Y, Othus, M, Araki, D, Wood, B L, Radich, J P, Halpern, A B, Mielcarek, M, Estey, E H, Appelbaum, F R, Walter, R B

Volltext

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell... von Walter, R B, Gyurkocza, B, Storer, B E, Godwin, C D, Pagel, J M, Buckley, S A, Sorror, M L, Wood, B L, Storb, R, Appelbaum, F R, Sandmaier, B M

Volltext

Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid Leukemia von Clift, R.A., Buckner, C.D., Appelbaum, F.R., Sullivan, K.M., Storb, R., Thomas, E.D.

Volltext

Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson von Othus, M, Kantarjian, H, Petersdorf, S, Ravandi, F, Godwin, J, Cortes, J, Pierce, S, Erba, H, Faderl, S, Appelbaum, F R, Estey, E

Volltext

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation von Castilla-Llorente, C, Martin, P J, McDonald, G B, Storer, B E, Appelbaum, F R, Deeg, H J, Mielcarek, M, Shulman, H, Storb, R, Nash, R A

Volltext

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center von Walter, R B, Othus, M, Burnett, A K, Löwenberg, B, Kantarjian, H M, Ossenkoppele, G J, Hills, R K, Ravandi, F, Pabst, T, Evans, A, Pierce, S R, Vekemans, M-C, Appelbaum, F R, Estey, E H

Volltext

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia von Buckley, S A, Appelbaum, F R, Walter, R B

Volltext

New drug approvals in acute myeloid leukemia: what’s the best end point? von Estey, E, Othus, M, Lee, S J, Appelbaum, F R, Gale, R P

Volltext

Prediction of CR following a second course of ‘7+3’ in patients with newly diagnosed acute myeloid leukemia not in CR after a first course von Othus, M, Mukherjee, S, Sekeres, M A, Godwin, J, Petersdorf, S, Appelbaum, F R, Erba, H, Estey, E

Volltext

Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed? von Zhou, Y, Wood, B L, Walter, R B, Becker, P S, Percival, M-E, Bar, M, Shaw, C, Gardner, K, Hendrie, P, Abkowitz, J, Appelbaum, F R, Estey, E

Volltext

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission von Walter, R B, Pagel, J M, Gooley, T A, Petersdorf, E W, Sorror, M L, Woolfrey, A E, Hansen, J A, Salter, A I, Lansverk, E, Stewart, F M, O'Donnell, P V, Appelbaum, F R

Volltext

Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report von Ostronoff, F, Othus, M, Ho, P A, Kutny, M, Geraghty, D E, Petersdorf, S H, Godwin, J E, Willman, C L, Radich, J P, Appelbaum, F R, Stirewalt, D L, Meshinchi, S

Volltext

Value of routine ‘day 14’ marrow exam in newly diagnosed AML von Yezefski, T, Xie, H, Walter, R, Pagel, J, Becker, P S, Hendrie, P, Sandhu, V, Shannon-Dorcy, K, Abkowitz, J, Appelbaum, F R, Estey, E

Volltext

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD von Furlong, T, Martin, P, Flowers, M E D, Carnevale-Schianca, F, Yatscoff, R, Chauncey, T, Appelbaum, F R, Deeg, H J, Doney, K, Witherspoon, R, Storer, B, Sullivan, K M, Storb, R, Nash, R A

Volltext

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study von Ho, P A, Alonzo, T A, Kopecky, K J, Miller, K L, Kuhn, J, Zeng, R, Gerbing, R B, Raimondi, S C, Hirsch, B A, Oehler, V, Hurwitz, C A, Franklin, J L, Gamis, A S, Petersdorf, S H, Anderson, J E, Reaman, G H, Baker, L H, Willman, C L, Bernstein, I D, Radich, J P, Appelbaum, F R, Stirewalt, D L, Meshinchi, S

Volltext

The quality of life of adult survivors of childhood hematopoietic cell transplant von Sanders, J E, Hoffmeister, P A, Storer, B E, Appelbaum, F R, Storb, R F, Syrjala, K L

Volltext

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate von Sievers, E.L., Appelbaum, F.R., Spielberger, R.T., Forman, S.J., Flowers, D., Smith, F.O., Shannon-Dorcy, K., Berger, M.S., Bernstein, I.D.

Volltext

Unrelated hematopoietic stem cell donors as research subjects von Appelbaum, F R

Volltext

Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia von Walter, R B, Laszlo, G S, Lionberger, J M, Pollard, J A, Harrington, K H, Gudgeon, C J, Othus, M, Rafii, S, Meshinchi, S, Appelbaum, F R, Bernstein, I D

Volltext